NANOGROUP IS AN INNOVATIVE BIOTECH COMPANY, MERGING DISRUPTIVE INNOVATION IN NANOTECHNOLOGY WITH UNIQUE RISK MANAGEMENT OPORTUNITIES

  • We are a complete R&D organization, which emerged at the intersection of science, medicine and business.
  • We focus on research areas with potential disruptive change.
  • We are looking to seal partnerships at the early development stage (pre-clinical trials)
  • Our technology is unique and protected globally by patents.
Nanogroup - nanotechnology for medicine

HISTORY

NanoGroup emerged as a result of disrupting inventions made by prof. Tomasz Ciach in the field of medical nanoparticles. High market potential and clear advantages allowed the company to secure funding from leading local VC funds. Early stage research was conducted in own lab located in Warsaw, Poland. Following research advancements and commencing pre-clinical trials, NanoGroup commenced cooperation with leading research facilities from US, China and Italy. As for today, Company is actively developing projects in two initial business areas.

Aside from the main research pipeline, NanoGroup successfully completed two side projects as CRO, one of which was widely commercialized.

Since 2017 NanoGroup is listed on Warsaw Stock Exchange.

NanoGroup

NanoGroup has three
subsidiaries dedicated to
different research areas

NanoVelos Platform:
polysaccharide nanocapsules
for targeted therapies
Respiratory gases transportation systems: Blood Substitute
& NanOX System
Radioisotopes
for diagnostics & treatment

BUSINESS MODEL

  • NanoGroup plans to sell licenses to early-stage solutions (pre-clinical or IND) to international biotech and pharma companies.
  • Upfront and milestones fees acquired are to finance several new development projects.
  • Most of the projects value will be acquired in royalties.

Market size estimates for our projects:

$750

MILLION
NanOX
system

$300

MILLION
NanoVelos
Platform
(per project)

$21

BILLION
Blood Substitute
Copyright © NanoGroup 2023

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.